Challenges and Trends in Geriatric Pharmacotherapy: Pharmacodynamics, Pharmacokinetics, and Personalized Therapeutic Strategies
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmacokinetics and Pharmacodynamics".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 69
Special Issue Editors
2. Pharmacy Directorate, Castilla y León Health Council, 47007 Valladolid, Spain
3. Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (Group CB21/13/00051), Carlos III Institute of Health, 28029 Madrid, Spain
Interests: pharmacology; pharmacoepidemiology; psychotropic drugs; big data analysis; real-world data; substance abuse; pharmacometrics; observational studies; meta-analysis
Special Issues, Collections and Topics in MDPI journals
Interests: psychoneuropharmacology; psychopharmacology; pharmacoepidemiology; toxicology; substance abuse
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to invite you to contribute to this Special Issue of Pharmaceutics entitled "Challenges and Trends in Geriatric Pharmacotherapy: Pharmacodynamics, Pharmacokinetics, and Personalized Therapeutic Strategies".
By 2050, approximately 1.5 billion people worldwide will be 65 years old or older, which is three times as many as in 2010. The progressive aging of the population, together with the increase in chronic diseases, is one of the greatest challenges facing pharmacotherapy today. Aging is associated with alterations that affect pharmacodynamics and pharmacokinetics, requiring the adoption of personalized treatment strategies. Another important issue in the elderly is complex drug regimens, which can lead to overdosing, underdosing, inappropriate drug selection, inadequate monitoring, side effects, and drug–drug interactions. In addition, inadequate pharmacologic treatment is directly related to decreased physical activity, movement disorders, decreased appetite, and depression, leading to increased hospitalization and mortality.
This Special Issue aims to report on the latest developments in pharmacokinetics and pharmacodynamics in order to develop personalized treatment strategies for the elderly. This Special Issue welcomes original research articles and reviews. Research areas may include, but are not limited to, pharmacokinetic studies, drug monitoring, drug–drug interactions, dose optimization in the elderly, the impact of aging on pharmacotherapy, and emerging personalized therapeutic strategies.
We look forward to receiving your contributions.
Dr. Eduardo Gutiérrez-Abejón
Prof. Dr. F. Javier Alvarez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacokinetics
- pharmacodynamics
- drug–drug interactions
- drug monitoring
- precision dosing
- therapeutic strategies
- individualized therapy
- personalized medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
